[抗血友病制剂的改进及其问题。4. 中等纯度和效价的凝血因子VIII制剂（RCG-5）] - Suppr | 超能文献

[Improvement in anti-hemophilic preparations and its problems. 4. Factor VIII preparation (RCG-5) with intermediate purity and potency].

作者信息

Yoshioka A

出版信息

Rinsho Ketsueki. 1988 May;29(5):649-54.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

[Improvement in anti-hemophilic preparations and its problems. 4. Factor VIII preparation (RCG-5) with intermediate purity and potency].[抗血友病制剂的改进及其问题。4. 中等纯度和效价的凝血因子VIII制剂（RCG-5）]

Rinsho Ketsueki. 1988 May;29(5):649-54.

2

[Improvement in anti-hemophilic preparations and arts problems. 1. Heat-treated concentrates].

Rinsho Ketsueki. 1988 May;29(5):628-34.

3

Human factor VIII:C purified using monoclonal antibody to von Willebrand factor.使用针对血管性血友病因子的单克隆抗体纯化的人凝血因子VIII：C。

Semin Hematol. 1988 Apr;25(2 Suppl 1):1-2.

4

[New prospects in the treatment of hemophilia. High-purity concentrates of factor VIII].[血友病治疗的新前景。高纯度凝血因子VIII浓缩剂]

Med Clin (Barc). 1993 May 1;100(17):655-8.

5

Factor VIII concentrate: what is "high purity"?

Thromb Haemost. 1994 Sep;72(3):483-4.

6

[Transmission of the human immunodeficiency virus by a dry heat-treated Factor VIII concentrate?].[人类免疫缺陷病毒是否可通过干热处理的凝血因子VIII浓缩剂传播？]

Klin Padiatr. 1988 Sep-Oct;200(5):375-9. doi: 10.1055/s-2008-1033736.

7

[Improvement in anti-hemophilic preparations and its problems. 7. Present status and future aspect of anti-hemophilic preparations].[抗血友病制剂的改进及其问题。7. 抗血友病制剂的现状与未来展望]

Rinsho Ketsueki. 1988 May;29(5):666-70.

8

Survey of non-U.S. hemophilia treatment centers for HIV seroconversions following therapy with heat-treated factor concentrates.

MMWR Morb Mortal Wkly Rep. 1987 Mar 13;36(9):121-4.

9

Factor VIII fractionation on aminohexyl Sepharose with possible reduction in hepatitis B antigen.在氨基己基琼脂糖上进行凝血因子 VIII 分级分离，可能降低乙型肝炎抗原。

Thromb Haemost. 1982 Aug 24;48(1):46-8.

10

Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.临床中间纯度凝血因子VIII浓缩物生产过程中凝血因子VIII复合物活性的变化

Thromb Haemost. 1981 Oct;46(3):597-601.